CELEX 02006R1907 · v20251023

ANNEX VII / STANDARD INFORMATION REQUIREMENTS FOR SUBSTANCES MANUFACTURED OR IMPORTED IN QUANTITIES OF ONE TONNE OR MORE ( 59 )


)

Column 1 of this Annex establishes the standard information required for:

(a) 

non-phase-in substances manufactured or imported in quantities of 1 to 10 tonnes;

(b) 

phase-in substances manufactured or imported in quantities of 1 to 10 tonnes and meeting the criteria in Annex III in accordance with Article 12(1)(a) and (b); and

(c) 

substances manufactured or imported in quantities of 10 tonnes or more.

Any other relevant physicochemical, toxicological and ecotoxicological information that is available shall be provided. For substances not meeting the criteria in Annex III only the physicochemical requirements as set out in section 7 of this Annex are required.

Column 2 of this Annex lists specific rules according to which the required standard information may be omitted, replaced by other information, provided at a different stage or adapted in another way. If the conditions are met under which column 2 of this Annex allows adaptations, the registrant shall clearly state this fact and the reasons for each adaptation under the appropriate headings in the registration dossier.

▼M51

Without prejudice to the information submitted for other forms, any relevant physicochemical, toxicological and ecotoxicological information shall include characterisation of the nanoform tested and test conditions. A justification shall be provided where QSARs are used or evidence is obtained by means other than testing, as well as a description of the range of the characteristics/properties of the nanoforms to which the evidence can be applied.

▼C1

In addition to these specific rules, a registrant may adapt the required standard information set out in column 1 of this Annex according to the general rules contained in Annex XI with the exception of Section 3 on substance-tailored exposure waiving. In this case as well, he shall clearly state the reasons for any decision to adapt the standard information under the appropriate headings in the registration dossier referring to the appropriate specific rule(s) in column 2 or in Annex XI ( 60 ).

Before new tests are carried out to determine the properties listed in this Annex, all available in vitro data, in vivo data, historical human data, data from valid (Q)SARs and data from structurally related substances (read-across approach) shall be assessed first. In vivo testing with corrosive substances at concentration/dose levels causing corrosivity shall be avoided. Prior to testing, further guidance on testing strategies should be consulted in addition to this Annex.

▼M64

Where a test method offers flexibility in the study design, for example in relation to the choice of dose levels, the chosen study design shall ensure that the data generated are adequate for hazard identification and risk assessment. To this end, testing shall be performed at appropriately high dose levels. If dose (concentration) selection is limited by the physicochemical properties or biological effects of the test substance, justification shall be provided.

▼C1

When, for certain endpoints, information is not provided for other reasons than those mentioned in column 2 of this Annex or in Annex XI, this fact and the reasons shall also be clearly stated.

7.   INFORMATION ON THE PHYSICOCHEMICAL PROPERTIES OF THE SUBSTANCE

COLUMN 1

STANDARD INFORMATION REQUIRED

COLUMN 2

SPECIFIC RULES FOR ADAPTATION FROM COLUMN 1

7.1.  State of the substance at 20 °C and 101,3 kPa

 

7.2.  Melting/freezing point

7.2.  The study does not need to be conducted below a lower limit of - 20 °C.

7.3.  Boiling point

7.3.  The study does not need to be conducted:

— for gases, or

— for solids which either melt above 300 °C or decompose before boiling. In such cases the boiling point under reduced pressure may be estimated or measured, or

— for substances which decompose before boiling (e.g. auto-oxidation, rearrangement, degradation, decomposition, etc.).

7.4.  Relative density

7.4.  The study does not need to be conducted if:

— the substance is only stable in solution in a particular solvent and the solution density is similar to that of the solvent. In such cases, an indication of whether the solution density is higher or lower than the solvent density is sufficient, or

— the substance is a gas. In this case, an estimation based on calculation shall be made from its molecular weight and the Ideal Gas Laws.

7.5.  Vapour pressure

7.5.  The study does not need to be conducted if the melting point is above 300 °C.

If the melting point is between 200 °C and 300 °C, a limit value based on measurement or a recognised calculation method is sufficient.

►M64  
7.6.  Surface tension of an aqueous solution  ◄

7.6.  The study need only be conducted if:

— based on structure, surface activity is expected or can be predicted, or

— surface activity is a desired property of the material.

If the water solubility is below 1 mg/l at 20 °C the test does not need to be conducted.

▼M51

7.7.  Water solubility

For nanoforms, in addition the testing of dissolution rate in water as well as in relevant biological and environmental media shall be considered.

7.7.  The study does not need to be conducted if:

— the substance is hydrolytically unstable at pH 4, 7 and 9 (half-life less than 12 hours), or

— the substance is readily oxidisable in water.

If the substance appears ‘insoluble’ in water, a limit test up to the detection limit of the analytical method shall be performed.

For nanoforms the potential confounding effect of dispersion shall be assessed when conducting the study.

For metals and sparingly soluble metal compounds, information on transformation/dissolution in aqueous media shall be provided.

7.8.  Partition coefficient n-octanol/water

7.8.  The study does not need to be conducted if the substance is inorganic. If the test cannot be performed (e.g. the substance decomposes, has a high surface activity, reacts violently during the performance of the test or does not dissolve in water or in octanol, or it is not possible to obtain a sufficiently pure substance), a calculated value for log P as well as details of the calculation method shall be provided.

For nanoforms the potential confounding effect of dispersion in octanol and water shall be assessed when conducting the study.

For nanoforms, whether of inorganic or organic substances, for which the partition coefficient n-octanol/water is not applicable the study of dispersion stability shall be considered instead.

▼C1

7.9.  Flash-point

7.9.  The study does not need to be conducted if:

— the substance is inorganic, or

— the substance only contains volatile organic components with flash-points above 100 °C for aqueous solutions, or

— the estimated flash-point is above 200 °C, or

— the flash-point can be accurately predicted by interpolation from existing characterised materials.

7.10.  Flammability

7.10.  The study does not need to be conducted:

— if the substance is a solid which possesses explosive or pyrophoric properties. These properties should always be considered before considering flammability, or

— for gases, if the concentration of the flammable gas in a mixture with inert gases is so low that, when mixed with air, the concentration is all time below the lower limit, or

— for substances which spontaneously ignite when in contact with air.

7.11.  Explosive properties

7.11.  The study does not need to be conducted if:

— there are no chemical groups associated with explosive properties present in the molecule, or

— the substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than -200, or

— the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties, but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 °C, or

— for mixtures of inorganic oxidising substances (UN Division 5.1) with organic materials, the concentration of the inorganic oxidising substance is:

— 

— less than 15 %, by mass, if assigned to UN Packaging Group I (high hazard) or II (medium hazard),

— less than 30 %, by mass, if assigned to UN Packaging Group III (low hazard).

Note: Neither a test for propagation of detonation nor a test for sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g.

7.12.  Self-ignition temperature

7.12.  The study does not need to be conducted:

— if the substance is explosive or ignites spontaneously with air at room temperature, or

— for liquids non flammable in air, e.g. no flash point up to 200 °C, or

— for gases having no flammable range, or

— for solids, if the substance has a melting point ≤ 160 °C, or if preliminary results exclude self-heating of the substance up to 400 °C.

7.13.  Oxidising properties

7.13.  The study does not need to be conducted if:

— the substance is explosive, or

— the substance is highly flammable, or

— the substance is an organic peroxide, or

— the substance is incapable of reacting exothermically with combustible materials, for example on the basis of the chemical structure (e.g. organic substances not containing oxygen or halogen atoms and these elements are not chemically bonded to nitrogen or oxygen, or inorganic substances not containing oxygen or halogen atoms).

The full test does not need to be conducted for solids if the preliminary test clearly indicates that the test substance has oxidising properties.

Note that as there is no test method to determine the oxidising properties of gaseous mixtures, the evaluation of these properties must be realised by an estimation method based on the comparison of the oxidising potential of gases in a mixture with that of the oxidising potential of oxygen in air.

7.14.  Granulometry

7.14.  The study does not need to be conducted if the substance is marketed or used in a non solid or granular form.

▼M51

7.14bis.  Dustiness

For nanoforms

7.14bis.  The study does not need to be conducted if exposure to granular form of the substance during its life-cycle can be excluded.

▼C1

8.   TOXICOLOGICAL INFORMATION

COLUMN 1

STANDARD INFORMATION REQUIRED

COLUMN 2

SPECIFIC RULES FOR ADAPTATION FROM COLUMN 1

▼M36

8.1.  Skin corrosion/irritation

8.1.  The study/ies do(es) not need to be conducted if:

— the substance is a strong acid (pH ≤ 2,0) or base (pH ≥ 11,5) and the available information indicates that it should be classified as skin corrosion (Category 1), or

— the substance is spontaneously flammable in air or in contact with water or moisture at room temperature, or

— the substance is classified as acute toxicity by the dermal route (Category 1), or

— an acute toxicity study by the dermal route does not indicate skin irritation up to the limit dose level (2 000  mg/kg body weight).

If results from one of the two studies under point 8.1.1 or 8.1.2 already allow a conclusive decision on the classification of a substance or on the absence of skin irritation potential, the second study need not be conducted.

8.1.1.  Skin corrosion, in vitro

 

8.1.2.  Skin irritation, in vitro

 

8.2.  Serious eye damage/eye irritation

8.2.  The study/ies do(es) not need to be conducted if:

— the substance is classified as skin corrosion, leading to classification as serious eye damage (Category 1), or

— the substance is classified as skin irritation and the available information indicates that it should be classified as eye irritation (Category 2), or

— the substance is a strong acid (pH ≤ 2,0) or base (pH ≥ 11,5) and the available information indicates that it should be classified as serious eye damage (Category 1), or

— the substance is spontaneously flammable in air or in contact with water or moisture at room temperature.

8.2.1.  Serious eye damage/eye irritation, in vitro

►M64  
8.2.1.  If results from a first in vitro study do not allow a conclusive decision on the classification of a substance or on the absence of eye irritation potential, (an)other in vitro study/studies for this endpoint shall be performed by the registrant or may be required by the Agency.  ◄

▼M42

8.3.  Skin sensitisation

Information allowing:

— a conclusion whether the substance is a skin sensitiser and whether it can be presumed to have the potential to produce significant sensitisation in humans (Cat. 1A), and

— risk assessment, where required.

The study(ies) under point 8.3.1 and 8.3.2 do not need to be conducted if:

— the substance is classified as skin corrosion (Category 1), or

— the substance is a strong acid (pH ≤ 2,0) or base (pH ≥ 11,5), or

— the substance is spontaneously flammable in air or in contact with water or moisture at room temperature.

8.3.1.  Skin sensitisation, in vitro/in chemico

Information from in vitro/in chemico test method(s) recognised according to Article 13(3), addressing each of the following key events of skin sensitisation:

(a)  molecular interaction with skin proteins;

(b)  inflammatory response in keratinocytes;

(c)  activation of dendritic cells.

The(se) test(s) do not need to be conducted if:

— an in vivo study according to point 8.3.2 is available, or

— the available in vitro/in chemico test methods are not applicable for the substance or are not adequate for classification and risk assessment according to point 8.3.

If information from test method(s) addressing one or two of the key events in column 1 already allows classification and risk assessment according to point 8.3, studies addressing the other key event(s) need not be conducted.

8.3.2.  Skin sensitisation, in vivo

An in vivo study shall be conducted only if in vitro/in chemico test methods described under point 8.3.1 are not applicable, or the results obtained from those studies are not adequate for classification and risk assessment according to point 8.3.

The murine local lymph node assay (LLNA) is the first-choice method for in vivo testing. Only in exceptional circumstances should another test be used. Justification for the use of another in vivo test shall be provided.

In vivo skin sensitisation studies that were carried out or initiated before 10 May 2017, and that meet the requirements set out in Article 13(3), first subparagraph, and Article 13(4) shall be considered appropriate to address this standard information requirement.

▼C1

8.4.  Mutagenicity

►M70  
8.4.  In case of a positive result in the in vitro gene mutation study in bacteria referred to in point 8.4.1 of this Annex, which gives rise to concern, the registrant shall perform an in vitro study referred to in Annex VIII, point 8.4.2. Based on the positive result of any of those in vitro genotoxicity studies, the registrant shall propose, or the Agency may require, an appropriate in vivo study referred to in Annex IX, point 8.4.4. The in vivo study shall address the chromosomal aberration concern or the gene mutation concern or both, as appropriate.
The in vitro gene mutation study in bacteria does not need to be conducted if this test is not applicable for the substance. In this case, the registrant shall provide a justification and perform an in vitro study referred to in Annex VIII, point 8.4.3. In case of a positive result in that study the registrant shall perform an in vitro cytogenicity study referred to in Annex VIII, point 8.4.2. Based on the positive result in any of those in vitro genotoxicity studies, or in case one of the Annex VIII in vitro tests is not applicable for the substance, the registrant shall propose, or the Agency may require, an appropriate in vivo study referred to in Annex IX, point 8.4.4. The in vivo study shall address the chromosomal aberration concern or the gene mutation concern or both, as appropriate.
The in vitro gene mutation study in bacteria referred to in point 8.4.1 and follow-up testing do not need to be conducted in any of the following cases:

— the substance is known to cause germ cell mutagenicity, meeting the criteria for classification in the hazard class germ cell mutagenicity category 1A or 1B, and appropriate risk management measures are implemented,

— the substance is known to be a genotoxic carcinogen, meeting the criteria for classification both in the hazard class germ cell mutagenicity category 1A, 1B or 2 and in the hazard class carcinogenicity category 1A or 1B, and appropriate risk management measures are implemented.

 ◄

▼M51

8.4.1.  In vitro gene mutation study in bacteria

►M70  
8.4.1.  The in vitro gene mutation study in bacteria does not need to be conducted for nanoforms where it is not appropriate. In such case, an in vitro study referred to in Annex VIII, point 8.4.3, shall be provided.  ◄

▼C1

8.5.  Acute toxicity

8.5.  The study/ies do(es) not generally need to be conducted if:

— the substance is classified as corrosive to the skin.

▼M51

8.5.1.  By oral route

8.5.1.  The study need not be conducted if

a study on acute toxicity by the inhalation route (8.5.2) is available.

For nanoforms, a study by the oral route shall be replaced by a study by the inhalation route (8.5.2), unless exposure of humans via inhalation is unlikely, taking into account the possibility of exposure to aerosols, particles or droplets of an inhalable size.

▼C1

9.   ECOTOXICOLOGICAL INFORMATION

COLUMN 1

STANDARD INFORMATION REQUIRED

COLUMN 2

SPECIFIC RULES FOR ADAPTATION FROM COLUMN 1

9.1.  Aquatic toxicity

 

▼M51

9.1.1.  Short-term toxicity testing on invertebrates (preferred species Daphnia)

►M70  — ◄

►M70  
9.1.1.  The study does not need to be conducted in any of the following cases:

— there are factors indicating that short-term aquatic toxicity is unlikely to occur, for instance if the substance is highly insoluble in water or the substance is unlikely to cross biological membranes,

— a long-term aquatic toxicity study on invertebrates is available.

— For nanoforms, the study may not be waived on the basis of high insolubility in water alone.

— The registrant may propose long-term toxicity testing instead of short-term toxicity testing.

— Long-term toxicity testing on invertebrates (preferred species Daphnia), (Annex IX, point 9.1.5) shall be proposed by the registrant or may be required by the Agency when it is unlikely that short-term toxicity testing can provide a true measure of the intrinsic aquatic toxicity of the substance, for instance:

— if the substance is poorly water soluble (solubility below 1 mg/L), or

— for nanoforms with low dissolution rate in the relevant test media.

 ◄

9.1.2.  Growth inhibition study aquatic plants (algae preferred)

►M70  
9.1.2.  The study does not need to be conducted if there are factors indicating that aquatic toxicity is unlikely to occur for instance if the substance is highly insoluble in water or the substance is unlikely to cross biological membranes.
For nanoforms, the study may not be waived on the basis of high insolubility in water alone.  ◄

▼C1

9.2.  Degradation

 

9.2.1.  Biotic

 

9.2.1.1.  Ready biodegradability

9.2.1.1.  The study does not need to be conducted if the substance is inorganic.

Any other relevant physicochemical, toxicological and ecotoxicological information that is available shall be provided.

Source: Content sourced from EUR-Lex and licensed under CC BY 4.0. This is an unofficial presentation; only the official EUR-Lex version is legally authentic.

Screen documents for chemicals